GLP-1 (Glucagon-like peptide-1) is a 30- or 31-amino-acid-long peptide hormone deriving from the tissue-specific posttranslational processing of the proglucagon peptide
Additionally, NSAIDs might be more effectively prescribed going forward, with NRF2-activating NSAIDs and non-NRF2-activating NSAIDs applied to the diseases theyre most likely to treat
Additionally, tirzepatide (Mounjaro, Zepbound) represents a dual GIP/GLP-1 receptor agonistnot a GLP-1 receptor agonistavailable for both diabetes management and weight loss, depending on the brand and indication
Manufactured in a facility that processes milk, soy, egg proteins, gluten, peanuts
While peptide therapy is generally safe, it's crucial to note that they may provide significant advantages in recovery and muscle development
The Late Show with Stephen Colbert